DD
Don Draper, Ph.D.
Computational single-cell scientist, single-cell / spatial multi-omics + ML/DL
Boston, MA 02135 (555) 019-2847 don.draper@example.com Google Scholar dondraper.example.com/cv

Profile

Moving from wet-lab immunology into computational neuroscience. I build methods that infer cellular identity, state, and interaction from large, incomplete single-cell and spatial data. Research objective: connect molecular cell identity to circuit structure and function by integrating connectomics with transcriptomics, growing into connectome-constrained circuit models.

Experience

Postdoctoral Researcher2025–2026
Nakdong University Wonju College of Medicine · Physiology / Cellular Systems Research Center
Developed deep-learning multimodal-integration models fusing imaging, transcriptomic, and clinical data into single predictive models.
Associate Director2023–2025
Meridian Immune Therapeutics Inc. · Basic Research, Seoul
Built in-house single-cell & spatial transcriptomics analysis code from scratch; led cross-functional NHP (cynomolgus, marmoset) EAE/MS multi-omic studies; oversaw regulatory documentation for an anti-CD25 humanized-antibody program.
Researcher2019–2021
Xenotransplantation Research Center, HNU · Seoul
Rhesus macaque tissue processing, longitudinal immune monitoring, CNS (brain/spinal cord) tissue handling.
Research Student, MOSAIC2020–2023
Multi-Organ Single-cell Atlas of Immune Cells, HNU · Genomic Medicine Institute
Contributed the founding proposal; executed within the funded program (500+ donors × 6 organs): milestone tracking, multi-site QC, multi-PI coordination.

Education

Ph.D., Biomedical Sciences2014–2023
Hangang National University · Seoul
Mapping Dendritic Cell Heterogeneity Across Chronic Inflammatory Contexts. Advisor: Min-Ho Suh, M.D., Ph.D.
M.S., Biomedical Sciences2012–2014
Hangang National University · Seoul
Enhanced LPS-Induced Monocyte Activation by Recombinant Human Soluble CD180.
B.S., Genetic Engineering2008–2012
Suwon Institute of Life Sciences · Suwon

Selected Publications

18total 17peer-reviewed 6first / co-first 1under review
1Reyes M*, Draper D*, Alvarez T*, et al. Conserved PDE9X short-isoform bias defines pathogenic Th1.17 state across human inflammatory diseases. Nature Immunology IF 27.7 · under review, 2026. UMI-aware BAM-level isoform analysis; scRNA + scTCR + snATAC integration; classifier AUC 0.812; 702 samples, 251,055 CD4⁺ T cells.
2Draper D*, Tanaka Y*, Truong P*, et al. Immune cell-enriched scRNA-seq unveils infiltrated CD8⁺ T resident memory cells and meningeal lymphatic endothelium in Parkinson's disease. Journal of Neuroimmunology IF 2.9 · 2025. 11,587 cells.
3Draper D*, Delgado J*, Moreau S, et al. Deciphering Dysfunctional Regulatory T Cells in Vitiligo. Allergy IF 12.6 · 2025.
4Alvarez J*, Draper D*, et al. Long-term control of diabetes by a baricitinib-based regimen after allo-islet transplantation in rhesus monkeys. Xenotransplantation IF 3.9 · 2024.
5Novak L*, Draper D*, et al. Intra-tumoral heterogeneity and immune escape of melanoma from chronic UV photodamage by spatial gene expression. JEADV IF 9.2 · 2022.
6Draper D*, et al. mTOR inhibitor-based immunosuppression in allogeneic islet transplantation. Islets IF 2.2 · 2019. Co-author: eBioMedicine (IF 11.1, 2024), JEADV (2024), Curr. Diabetes Reports (2021).